Biologics and vaccines manufacturing demand has grown in the last three years, prompting an expansion in the base of manufacturers here, according to the Singapore Economic Development Board (EDB).
EDB added development in Singapore’s biopharmaceutical industry has been stepped up to accelerate growth opportunities in Asia through Singapore.
EDB made the comments in a statement issued at the opening of life sciences company Pall Corporation’s new Life Sciences Centre at the Singapore Science Park II.
The US$1 million investment by Pall Corporation will serve as a central hub for Pall Life Sciences’ business and operational activities across the region.
The company said it decided to set up in Singapore as demand for biotechnology process development and training is acute.
Commenting on the economic outlook in the US and Europe, Pall Corporation said it will not be deterred by the gloom and will continue to invest in its operations in Asia.
Pall Life Sciences Asia president Stefan Egli said: “In Asia we have a lot of opportunities and that is not affected at the moment.
“We’re still planning to grow and invest in the region. The development here is substantial and will sustain.”
Source: CNA
Business & Investment Opportunities
YourVietnamExpert is a division of Saigon Business Corporation Pte Ltd, Incorporated in Singapore since 1994. As Your Business Companion, we propose a range of services in Consulting, Investment and Management, focusing three main economic sectors: International PR; Healthcare & Wellness;and Tourism & Hospitality. We also propose Higher Education, as a bridge between educational structures and industries, by supporting international programs. Sign up with twitter to get news updates with @SaigonBusinessC. Thanks.
No comments:
Post a Comment